In contrast to its uncertain role in the primary tumor, PTHrP has a well-defined deleterious effect on patient outcomes in later stages of disease progression, where its expression drives bone colonization and metastatic tumor growth [11, 26, 29]. This evidence concerns the gene PTHLH and metastatic neoplasm.